In addition, mutations that affect intron consensus sequences at the splice and branch sites of BRCA1 and BRCA2 and those that create ectopic splice sites account for 15% of point mutations associated with breast and ovarian cancer (Krawczak et al. This evidence concerns the gene BRCA1 and ovarian cancer.